The Difference Between PN and PDRN — the Same Substance, Different Chain Lengths, and the Level of Evidence
PN and PDRN are mixed up under the name “salmon injection.” Some places say PN, others PDRN. Are they different ingredients? This article sets out, without exaggeration, what the two names refer to and what level human research in this line has actually reached. To give the conclusion first: knowing the thickness of the evidence helps more in consultation than the difference in names.
The short answer
PN (polynucleotide) and PDRN (polydeoxyribonucleotide) are substances of the same line purified from salmon · trout and similar fish; PDRN refers to the short-chain segment and PN the long one. A systematic review gathering 9 PN studies and 219 people rated the evidence quality as “low to moderate” (Lampridou 2025), and I couldn't confirm any trial directly comparing PN and PDRN in humans. Neither ingredient is a volume-filling material. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, +82-53-428-2700) uses Rejuran, a PN preparation, and at consultation we talk first about your concern and the limits of the evidence rather than ingredient names (clinical judgement).
Are PN and PDRN different ingredients?
They aren't different substances but chain-length segments of the same substance. Both are polymers of long chains of nucleotides from DNA; the shorter-chain one is called PDRN and the longer PN. The source is mainly salmonid fish such as salmon · trout.
| Item | PDRN | PN |
|---|---|---|
| Substance | Polydeoxyribonucleotide | Polynucleotide |
| Chain length | Short segment | Long segment |
| Source | Purified from salmonid fish | Purified from salmonid fish |
| Product used at Miso Clinic | — | Rejuran (formulations with PN + hyaluronic acid + lidocaine, etc.) |
Exactly which length segment each product uses varies by product. This article doesn't give molecular-weight figures because I haven't confirmed any from original sources.
Why are they called by different names?
Because if chain length differs, the injection's properties (viscosity, how it stays in the dermis) can differ. But I couldn't confirm any human trial measuring under the same conditions how much the length difference translates into different results in human skin.
So sentences like “PN is better than PDRN,” or the reverse, are hard to say on current evidence. At consultation it's more accurate to check the three things below rather than the name.
- The product's ingredient labelling — whether it's PN and whether other ingredients (hyaluronic acid · lidocaine) are mixed in
- The product's approval classification — you can check it with an approval number lookup
- Whether your concern is on the texture · hydration side or the volume side
What level is the human evidence for PN?
To be honest, it's “there, but not thick.”
| Data | Design | What it showed |
|---|---|---|
| Lee 2022 | 27 people · randomized · double-blind · split-face (hyaluronic acid control) | No difference on subjective scales; improvement rates in roughness · pore volume · elasticity · hydration higher on the PN side |
| Jeong 2020 | 30 people, compared with PCL | No significant difference in wrinkle · global improvement scales at 12 weeks |
| Jeon 2025 | 15 people, comparing PN formulation designs | Differences in pain · embossing; no difference in wrinkle scale |
| Lampridou 2025 | Systematic review, 9 studies, 219 people | Evidence quality “low to moderate” |
A 2024 Int J Mol Sci review also dealt separately with the grade and limits of PN evidence. It should be read alongside the facts that samples are small, follow-up short, and differences more often show on device-measured indicators than on subjective cosmetic scales.
Is there a study directly comparing PN and PDRN?
There's no confirmed data. I couldn't find any trial giving PN and PDRN separately to the same people and comparing results. So this article doesn't put the difference in effect between the two into numbers.
Comparisons online like “PN is X times more” mostly have unconfirmed sources. When a number comes up, ask how many people, compared with what, and for how long. Things to watch when choosing evidence are also written in Five retracted papers in cosmetic treatment evidence.
How should PN for the eye area be viewed?
Under the eyes is a spot where PN often comes up. 2026 J Clin Med literature dealt separately with the indications and limits of hyaluronic acid filler and PN under the eyes. Expert opinion also emphasizes that PN isn't a volumizer.
- Thin under-eye skin with fine lines · dryness as the concern — PN is a candidate.
- The tear trough is grooved and shadowed — it's a structural problem, so PN alone is difficult.
- Dark circles — in a classification of 65 people, 78% were mixed (Huang 2014). First separate colour · vessels · structure.
Eye-area options are in Choosing an eye-area skin booster and Dealing with under-eye hollows and the lid-cheek groove.
Which skin does PN suit, and what doesn't it suit?
| Concern | Judgement |
|---|---|
| Thinned, roughened texture · pores | Candidate |
| Sensitive skin · first booster | A candidate — a material that breaks down, so a relatively low-burden start |
| Hollow cheeks | Not a fit — that's for filling materials |
| Sagging facial contour | Not a fit — that's for lifting |
| Dermis so thin the material itself is lacking | Consider the hADM line too |
Skin that suits Rejuran is in Skin that suits Rejuran, and the difference from hADM in hADM and PN.
How does Miso Clinic use PN?
Miso Clinic uses Rejuran as its PN preparation. We present 3–4 sessions 3–4 weeks apart as one course, and after the course we top up based on condition rather than the calendar (clinical judgement).
- We divide the concern first rather than the ingredient name — texture · thickness · volume.
- We tell you first that the evidence isn't thick.
- We don't layer it with other boosters on the same day — because we need to be able to tell the cause of any reaction.
- If you're pregnant · breastfeeding or have inflammation at the treatment site, we postpone.
To see several lines at a glance, go back to the skin booster map.
PN and PDRN: frequently asked questions
Are PN and PDRN different ingredients?
They aren't different substances but chain-length segments of the same substance. PDRN is the shorter one and PN the longer, and both are purified from salmonid fish.
Is PN more effective than PDRN?
I couldn't confirm any trial directly comparing PN and PDRN in humans. So there's no basis to say which is better.
Is the evidence for PN sufficient?
It exists but isn't thick. A systematic review gathering 9 studies and 219 people rated the evidence quality as low to moderate, and the representative trial is on the scale of 27 people.
Does PN fill hollow under-eyes or cheeks?
PN isn't a volume-filling material. It targets texture · hydration · fine-line indicators; for hollowing we look at filling materials or other methods.
Is Rejuran PN or PDRN?
Rejuran is a PN preparation. Depending on the formulation, it also contains hyaluronic acid and lidocaine.
Where can I get a PN skin booster consultation in Daegu?
Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700; weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break); closed Sundays · public holidays.
Clinical columns to read next
- Skin regeneration injections: what are Rejuran · PDRN?
- Skin boosters in Daegu: where to start
- Skin that suits Rejuran
- CellREDM · Re2O and Rejuran — they put in different things
- Rejuran in Daegu — what goes in and what it targets
- Choosing an eye-area skin booster
- Six ingredient lines of collagen boosters: what's confirmed
Product reference
Product notes: Rejuran · all boosters compared
Clinic
This column was written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu. The treatment criteria and injection design are written exactly as we actually use them.
| Medical Director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu (Exit 1, Kyungpook National University Hospital Station) · tower parking in the building |
| Phone | 053-428-2700 |
| KakaoTalk consultation | Miso Clinic Daegu channel |
| KakaoTalk channel | Add the channel |
| Opening hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Clinical column | See all columns |
| Reference library | All booster and lifting device references |
References
- Level of PN evidence — Polynucleotides in Aesthetic Medicine: Current Practices and Perceived Effectiveness, Int J Mol Sci 2024 (evidence grade and limitations) · Expert Perspectives: Evidence-Based Applications of Polynucleotides, Clin Cosmet Investig Dermatol (that it is not a volumiser).
- Systematic review of PN — Lampridou S et al., J Cosmet Dermatol 2025;24(2):e16721, PMID 39645667. 9 studies, 219 people; evidence quality “low to moderate.” (Cited from /column/daegu-rejuran-skin-fit/)
- Eye-area comparison trial of PN and hyaluronic acid — Lee YJ et al., J Dermatolog Treat 2022;33(1):254–260, PMID 32248707. Randomised · double-blind · split face, 27 people, three sessions 2 weeks apart. No difference between sides in subjective cosmetic scales (VAS · GAIS); improvement rates for roughness · pore volume · elasticity · hydration higher on the PN side. No difference in dermal density. (Cited from /column/daegu-rejuran-skin-fit/)
- PN vs PCL — Jeong GJ et al., J Cosmet Dermatol 2020;19(7):1593–1599, PMID 31680395. 30 people; no significant difference in wrinkle · global improvement scales at 12 weeks. (Cited from /column/daegu-rejuran-skin-fit/)
- PN formulation design and pain · embossing — Jeon W et al., Aesthetic Plast Surg 2025;50(7):2723–2730, PMID 41361144. 15 people. Pain VAS 3.39 vs 5.04, embossing 13.3% vs 56.7%, erythema 40% vs 60%. No difference in wrinkle · global improvement scales. (Cited from /column/daegu-rejuran-skin-fit/)
- Under-eye HA and PN — Hyaluronic Acid Fillers Versus Polynucleotides for Under-Eye Rejuvenation, Journal of Clinical Medicine 2026. Literature covering indications and limits for use around the eyes.
- Types of dark circles — Huang YL et al., Int J Dermatol 2014;53(2):164. 65 people classified — pigmented 5% · vascular 14% · structural 3% · mixed 78%.
- Rejuran HB PLUS — made by Pharma Research, PN + hyaluronic acid + lidocaine, Korean medical device. The course of 3–4 sessions 3–4 weeks apart is Miso Clinic’s recommended design.
- Korean medical advertising law — Medical Service Act Article 56(2), which prohibits testimonial advertising, comparison with other medical institutions and superlative claims.
- Miso Clinic clinical guidelines — criteria for indications, design by area, pre-treatment explanation and consent. The source of sentences marked “clinical judgement” in this column.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.